Jun Dong
Cited by
Cited by
Geometric interpretation of gene coexpression network analysis
S Horvath, J Dong
PLoS comput biol 4 (8), e1000117, 2008
Understanding network concepts in modules
J Dong, S Horvath
BMC systems biology 1 (1), 1-20, 2007
Weighted gene coexpression network analysis: state of the art
W Zhao, P Langfelder, T Fuller, J Dong, A Li, S Hovarth
Journal of biopharmaceutical statistics 20 (2), 281-300, 2010
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
Y Lee, AC Scheck, TF Cloughesy, A Lai, J Dong, HK Farooqi, LM Liau, ...
BMC medical genomics 1 (1), 1-12, 2008
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis
WB Pope, JH Chen, J Dong, MRJ Carlson, A Perlina, TF Cloughesy, ...
Radiology 249 (1), 268-277, 2008
Genomic landscape of meningiomas
Y Lee, J Liu, S Patel, T Cloughesy, A Lai, H Farooqi, D Seligson, J Dong, ...
Brain Pathology 20 (4), 751-762, 2010
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2
MRJ Carlson, WB Pope, S Horvath, JG Braunstein, P Nghiemphu, CL Tso, ...
Clinical Cancer Research 13 (9), 2592-2598, 2007
Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone
M Kappadakunnel, A Eskin, J Dong, SF Nelson, PS Mischel, LM Liau, ...
Journal of neuro-oncology 96 (3), 359-367, 2010
Celsius: a community resource for Affymetrix microarray data
A Day, MRJ Carlson, J Dong, B D O'Connor, SF Nelson
Genome biology 8 (6), 1-13, 2007
Disease gene characterization through large-scale co-expression analysis
A Day, J Dong, VA Funari, B Harry, SP Strom, DH Cohn, SF Nelson
PloS one 4 (12), e8491, 2009
Weighted gene co-expression network analysis identifies biomarkers in glycerol kinase deficient mice
NK MacLennan, J Dong, JE Aten, S Horvath, L Rahib, L Ornelas, ...
Molecular genetics and metabolism 98 (1-2), 203-214, 2009
A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer
TW Kim, A Elme, Z Kusic, JO Park, AA Udrea, SY Kim, JB Ahn, ...
British journal of cancer 115 (10), 1206-1214, 2016
Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors
G Potikyan, KA France, MRJ Carlson, J Dong, SF Nelson, CT Denny
Laboratory investigation 88 (12), 1291-1302, 2008
Preferential gene expression in the limbus of the vervet monkey
Z Ding, J Dong, J Liu, SX Deng
Molecular vision 14, 2031, 2008
PARTNER: an open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous …
LJ Wirth, S Dakhil, G Kornek, R Axelrod, D Adkins, S Pant, P O’Brien, ...
Oral oncology 61, 31-40, 2016
Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer
J Wang, G Hechmati, J Dong, GA Maglinte, B Barber, JY Douillard
Current medical research and opinion 32 (3), 459-465, 2016
A two-step estimation approach for logistic varying coefficient modeling of longitudinal data
J Dong, JP Estes, G Li, D Şentürk
Journal of statistical planning and inference 174, 38-51, 2016
Predictor model of root caries in older adults: reporting of evidence to the translational evidence mechanism
JG Bauer, S Spackman, J Dong, N Garrett
The open dentistry journal 4, 124, 2010
Assessing temporal agreement between central and local progression‐free survival times
D Zeng, E Cornea, J Dong, J Pan, JG Ibrahim
Statistics in medicine 34 (5), 844-858, 2015
Pattern mixture models for clinical validation of biomarkers in the presence of missing data
F Gao, J Dong, D Zeng, A Rong, JG Ibrahim
Statistics in medicine 36 (19), 2994-3004, 2017
The system can't perform the operation now. Try again later.
Articles 1–20